| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/10/2006 | WO2006082088A1 Ester-linked gemini surfactant compounds for use in gene therapy |
| 08/10/2006 | WO2006081976A1 Mutant of fluorescent protein cgfp, and the use thereof |
| 08/10/2006 | WO2006081831A1 Method of generating translationally active linear dna molecules and use thereof in array formats |
| 08/10/2006 | WO2006081718A1 Kit and method for the detection of anti-hepatitis c virus (hcv) antibodies |
| 08/10/2006 | WO2006081669A1 Anti-t cell and autoantigen treatment of autoimmune disease |
| 08/10/2006 | WO2006081629A1 Adenoviral vectors comprising a nucleic acid encoding a mhc class i molecule and the use of such vectors in cancer therapy. |
| 08/10/2006 | WO2006081597A1 Method for the purification of dna/rna of proteins and cellular residual substances in cell lysate |
| 08/10/2006 | WO2006067565A3 Truncated gabab receptor and methods of use thereof |
| 08/10/2006 | WO2006066066A3 Chimeric vectors |
| 08/10/2006 | WO2006059130A9 Manipulation of starch granule size and number (ii) |
| 08/10/2006 | WO2006059081A3 Methods of treatment using melanopsin |
| 08/10/2006 | WO2006059069A3 Ion channel |
| 08/10/2006 | WO2006055931A3 Vectors for stable gene expression |
| 08/10/2006 | WO2006054326B1 Animal model for studying substances with cardiotherapeutic and anti-hypertensive activity |
| 08/10/2006 | WO2006049777A3 Nucleic acid sequences encoding luciferase for expression in filamentous fungi |
| 08/10/2006 | WO2006048459A3 Selection of host cells expressing protein at high levels |
| 08/10/2006 | WO2006042145A3 THE RICE BACTERIAL BLIGHT DISEASE RESISTANCE GENE xa5 |
| 08/10/2006 | WO2006033689A3 Aav mediated gene delivery to cochlear cells |
| 08/10/2006 | WO2006017855A3 Methods and compositions for regulation of stem cell survival, proliferation, and differentiation by protein ubiquitination |
| 08/10/2006 | WO2006013468A3 Polypeptide |
| 08/10/2006 | WO2006005585A3 Secreted polypeptide species differentially expressed during pregnancy |
| 08/10/2006 | WO2005121376A3 Hiv variants showing a novel resistance mechanism against protease inhibitors, diagnostic assays for detecting the variant, and methods for identifying drugs effective against the resistant variant |
| 08/10/2006 | WO2005115481A3 Nuclease resistant double-stranded ribonucleic acid |
| 08/10/2006 | WO2005113791A3 Methods of identifying modulators of bacterial type iii protein secretion system |
| 08/10/2006 | WO2005103716A3 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 08/10/2006 | WO2005100573A3 Fungal promoters for expressing a gene in a fungal cell |
| 08/10/2006 | WO2005099337A3 Therapeutic peptides |
| 08/10/2006 | WO2005085280A3 HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE |
| 08/10/2006 | WO2005084190A3 Methods and compostions for targeted cleavage and recombination |
| 08/10/2006 | WO2005083065A1 High glyphosate-tolerant epsp synthase from halomonas variabilis and its encoding sequence |
| 08/10/2006 | WO2005077048A3 Immune modulation by regulating expression of the “minor” gene in immune dendritic cells |
| 08/10/2006 | WO2005043593A3 System for processing a workpiece |
| 08/10/2006 | WO2005027962A9 4’-thionucleosides and oligomeric compounds |
| 08/10/2006 | WO2005017101A3 Avian adenoassociated virus (aaav) and uses thereof |
| 08/10/2006 | WO2004087886A3 Modified adenoviral e1a constructs and methods of use thereof |
| 08/10/2006 | WO2004071467A3 Production of very long chain polyunsaturated fatty acids in oilseed plants |
| 08/10/2006 | WO2004037848A3 Process for determining target function and identifying drug leads |
| 08/10/2006 | US20060179521 Garden bean named H24953 |
| 08/10/2006 | US20060179520 Garden bean named H24956 |
| 08/10/2006 | US20060179519 Modified plants |
| 08/10/2006 | US20060179518 Plant proteins having an abscisic acid binding site and methods of use |
| 08/10/2006 | US20060179517 The rice restorer gene to the rice bt type cytoplasmic male sterility |
| 08/10/2006 | US20060179516 DNA of given sequence; transforming seeds and cells using expression cassettes; |
| 08/10/2006 | US20060179515 Sugar and Lipid Metabolism Regulators in Plants |
| 08/10/2006 | US20060179514 Methods for the production of multimeric protein complexes, and related compositions |
| 08/10/2006 | US20060179513 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars |
| 08/10/2006 | US20060179512 Nitrogen-regulated sugar sensing gene and protein and modulation thereof |
| 08/10/2006 | US20060179511 Transgenic plants with enhanced agronomic traits |
| 08/10/2006 | US20060179510 Inbred cantaloupe line I446 |
| 08/10/2006 | US20060179509 Soybean cultivar 4805442 |
| 08/10/2006 | US20060179508 Soybean cultivar 4921237 |
| 08/10/2006 | US20060179507 Nucleic acid encoding protein of given sequence; hydroxylation of taxoid; used in production of anti-cancer drugs paclitaxel and taxol |
| 08/10/2006 | US20060179505 Transgenic mice containing channel activating protease 1 (CAP1) gene disruptions |
| 08/10/2006 | US20060179504 Transgenic mice containing deubiquitinated enzyme gene disruptions |
| 08/10/2006 | US20060179503 Transgenic mice containing MSK2 serine/threonine kinase gene disruptions |
| 08/10/2006 | US20060179502 Automated gene-targeting using non-toxic detectable markers |
| 08/10/2006 | US20060179501 Transgenic mice expressing human cd20 |
| 08/10/2006 | US20060179500 Methods and vectors for improving nucleic acid expression |
| 08/10/2006 | US20060179498 Reverse breeding |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060179494 Non-human animal exhibiting bone metastasis of tumor cells |
| 08/10/2006 | US20060179493 Transgenically produced non-secreted proteins |
| 08/10/2006 | US20060178842 Methods and computer products for predicting nucleic acid hybridization affinity |
| 08/10/2006 | US20060178837 Computer-assisted means for assessing lifestyle risk factors |
| 08/10/2006 | US20060178508 Method for labeling DNA and RNA |
| 08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
| 08/10/2006 | US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof |
| 08/10/2006 | US20060178502 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 08/10/2006 | US20060178337 Method for diagnosing aplasia of corpus callosum |
| 08/10/2006 | US20060178335 Methods and means for obtaining modified phenotypes |
| 08/10/2006 | US20060178334 Double-stranded and single-stranded RNA molecules with 5 ' triphosphates and their use for inducing interferon |
| 08/10/2006 | US20060178333 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof |
| 08/10/2006 | US20060178331 Antisense oligonucleotides targeting folate receptor alpha, and the use thereof |
| 08/10/2006 | US20060178330 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 |
| 08/10/2006 | US20060178329 Rna sequence for therapy of cancer; control degradation and block transscription of messenger Rna that is translation product of target gene |
| 08/10/2006 | US20060178328 Brain delivery of small interfering RNA or vectors containing the DNA encoding for small interfering RNA; beneficial effects on improving memory and/or cognitive function in a subject. |
| 08/10/2006 | US20060178327 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation and function of small interfering RNA in vivo and in vitro |
| 08/10/2006 | US20060178326 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 08/10/2006 | US20060178324 Lipophilic derivatives of double-stranded ribonucleic acid |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178308 Complement inhibitor |
| 08/10/2006 | US20060178297 Systems and methods for silencing expression of a gene in a cell and uses thereof |
| 08/10/2006 | US20060178293 Cardiotonic polypeptides |
| 08/10/2006 | US20060178292 Methods and compositions of ecdysozoan molt inhibition |
| 08/10/2006 | US20060177934 Lentiviral LTR-deleted vector |
| 08/10/2006 | US20060177933 Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing |
| 08/10/2006 | US20060177932 Expansion agents for stem cells |
| 08/10/2006 | US20060177931 Apparatus and method for co-culturing of cells |
| 08/10/2006 | US20060177919 Polypeptide having amidohydrolase activity capable of hydrolysing 3,3,3-trifluoro-2-hydroxy-2-methyl propionamide in form of the racemate or of an optically active isomer; obtainable from Klebsiella oxytoca, Pseudomonas, Rhodococcus opacus, Arthrobacter ramosus, Bacillus |
| 08/10/2006 | US20060177915 Method for the production of glycerol by recombinant organisms |
| 08/10/2006 | US20060177912 Nucleotide sequences which code for the dep34 gene |
| 08/10/2006 | US20060177905 UDP-glucosyltransferases |
| 08/10/2006 | US20060177903 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| 08/10/2006 | US20060177902 mammalian cytokine receptor proteins with affinity for IL-13; allergic conditions, asthma, immune complex disease; lupus, nephrotic syndrome, nephritis, glomerulonephritis, thyroiditis and Grave's disease |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177900 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 08/10/2006 | US20060177898 Methods for producing modified glycoproteins |
| 08/10/2006 | US20060177897 PR1550 polypeptides and nucleic acids encoding the same |
| 08/10/2006 | US20060177895 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA polymerase and thereby prevent the assembly of a poised transcriptional complex |